Article Versions Notes

Elkina NA, Grishchenko MV, Shchegolkov EV, Makhaeva GF, Kovaleva NV, Rudakova EV, Boltneva NP, Lushchekina SV, Astakhova TY, Radchenko EV, et al. New Multifunctional Agents for Potential Alzheimer’s Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones. Biomolecules. 2022; 12(11):1551. https://doi.org/10.3390/biom12111551

Elkina, Natalia A., Maria V. Grishchenko, Evgeny V. Shchegolkov, Galina F. Makhaeva, Nadezhda V. Kovaleva, Elena V. Rudakova, Natalia P. Boltneva, Sofya V. Lushchekina, Tatiana Y. Astakhova, Eugene V. Radchenko, and et al. 2022. "New Multifunctional Agents for Potential Alzheimer’s Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones" Biomolecules 12, no. 11: 1551. https://doi.org/10.3390/biom12111551

Elkina, N. A., Grishchenko, M. V., Shchegolkov, E. V., Makhaeva, G. F., Kovaleva, N. V., Rudakova, E. V., Boltneva, N. P., Lushchekina, S. V., Astakhova, T. Y., Radchenko, E. V., Palyulin, V. A., Zhilina, E. F., Perminova, A. N., Lapshin, L. S., Burgart, Y. V., Saloutin, V. I., & Richardson, R. J. (2022). New Multifunctional Agents for Potential Alzheimer’s Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones. Biomolecules, 12(11), 1551. https://doi.org/10.3390/biom12111551